【摘要】 探讨解决一稿两投、重复发表问题的有效措施。给 47刊发了统一的调查信 ,收回 2 5封 (刊 )。 2 5刊中存在一稿两投问题的稿件有 14篇 ,涉及 9个刊 ,占 3 6%。其中 6篇没有造成重复发表的事实 ,8篇形成了重复发表的事实 ,占 5 7.14 %。结论 :1)同一篇论文将作者的署名顺序变化后 ,投寄不同的期刊 ,属一稿两投或多投 ;2 )投到不同期刊的论文 ,半数以上内容 (包括资料或讨论部分 )相同时 ,属一稿两投 ;3 )同一篇论文将题名变化后投寄不同的期刊 ,属一稿两投 ;4)同一组资料从不同的角度去写作 (研究问题 ) ,不属一稿两投 ;5 )同一篇论文以不同的文字发表属平行发表 ,不属一稿两投或多投 ;6)同一篇论文在内部资料与公开发行的刊物上分别发表 ,不属一稿两投。处理一稿两投 ,尤其重复发表问题要从严 ,但重在预防 :1)加强宣传 ,提高作者、编者的法律意识 ;2 )在相关期刊上公布有关的处罚规定 ,以达到警示目的 ;3 )要求作者在授权书中承诺不存在一稿两投、重复发表问题 ;4)统一介绍信的格式与内容 ,依靠单位审查把关 ;5 )实现资源共享联网查询 ;6)依靠审稿人把关更多还原

【Abstract】 We investigated multiple submissions and duplicate publi cation in CMA(Chinese Medical Association)-entrusted publication of medic al journals and took countermeasures for prevention. Questionnaires were sen t to 47 journals, and 25 responded. Nine(36%) of the 25 journals reported mu ltiple submissions of 14 manuscripts, of which 8(57.14%) constituted dupli cate publication. Duplicate publication varies in form: same content, diff erent sequence of authorship; submission to different journals, almost the same content in material and discussion sections; and same content, different tit les. Prevention and penalty inclu de ethical and law education, publication of retraction notice and penalties; c ommitment to originality of research reports without multiple submission and red undant publication; standardization of covering letter and institutional sup ervision; establishment of manuscripts tracking system for thr CMA-entrus- ted publication of medical journals; gate keeping of peer-reviewers.更多还原